Korean J Obstet Gynecol.  2011 Sep;54(9):566-569. 10.5468/KJOG.2011.54.9.566.

A case of lymphogranuloma venereum in woman

Affiliations
  • 1Department of Obstetrics and Gynecology, Soonchunhyang University Cheonan Hospital, Soonchunhyang University College of Medicine, Cheonan, Korea. drsook@schmc.ac.kr
  • 2Department of Plastic Surgery, Soonchunhyang University Cheonan Hospital, Soonchunhyang University College of Medicine, Cheonan, Korea.
  • 3Department of Pathology, Soonchunhyang University Cheonan Hospital, Soonchunhyang University College of Medicine, Cheonan, Korea.

Abstract

Lymphogranuloma venereum (LGV) is a rare sexually transmitted disease caused by chlamydia trachomatis serotypes L1-L3. The peak incidence occurs in persons 29 to 47 years old, and men are six times more likely than women to manifest clinical infection. The disease clinically manifests in three stages: a primary lesion consisting of a superficial ulcer or erosion, a secondary stage with prominent lymphadenopathy and a later stage with disease manifestations such as fibrosis, fistula, and anorectal strictures. The diagnosis of LGV is based on clinical suspicion, epidemiologic information, and the exclusion of other causes of inguinal lymphadenopathy. Diagnosis of LGV may be difficult. Patients with a clinical syndrome consistent with LGV, including genital ulcer with lymphadenopathy, should be treated for LGV. Recently we have experienced a case of LGV in 44-years-old women with inguinal bubo and sclerosing fibrous skin. We treated her with doxycycline and advancement flap.

Keyword

Lymphogranuloma venereum; Chlamydia trachomatis

MeSH Terms

Chlamydia trachomatis
Constriction, Pathologic
Doxycycline
Female
Fibrosis
Fistula
Humans
Incidence
Lymphatic Diseases
Lymphogranuloma Venereum
Male
Sexually Transmitted Diseases
Skin
Ulcer
Doxycycline
Full Text Links
  • KJOG
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2026 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr